Physician profile
Kunjan Patel
NPI 1336360965
$788.93
in general payments reported to CMS, 2019-2025
8 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2021: $22.03 · 2023: $127 · 2024: $99.24 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $229.46 | 2019-2025 | Bridion, Keytruda, Lynparza |
| Flowonix Medical Incorporated | $190.33 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Intercept Pharmaceuticals, INC. | $99.29 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.44 | 2019-2021 | |
| Eagle Pharmaceuticals, INC. | $65.13 | 2023 | |
| Heron Therapeutics, INC. | $22.20 | 2024 | Aponvie |
| Antares Pharma, INC. | $17.08 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunjan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.